Safety and efficacy of Rapamune® (Sirolimus) in kidney transplant recipients: results of a prospective post-marketing surveillance study in Korea
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2369
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Safety and efficacy of Rapamune® (Sirolimus) in kidney transplant recipients: results of a prospective post-marketing surveillance study in Korea ; volume:19 ; number:1 ; day:13 ; month:8 ; year:2018 ; pages:1-11 ; date:12.2018
BMC nephrology ; 19, Heft 1 (13.8.2018), 1-11, 12.2018
- Creator
-
Jeon, Hee Jung
- Contributor
-
Lee, Hahn-Ey
Yang, Jaeseok
SpringerLink (Online service)
- DOI
-
10.1186/s12882-018-1002-6
- URN
-
urn:nbn:de:101:1-2018102715443583119494
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:59 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Jeon, Hee Jung
- Lee, Hahn-Ey
- Yang, Jaeseok
- SpringerLink (Online service)
Other Objects (12)
Sirolimus in renal transplant recipients with malignancies in Germany
Histological spectrum of pulmonary manifestations in kidney transplant recipients on sirolimus inclusive immunosuppressive regimens
Immunomonitoring in Transplant Recipients
Malignant tumors in organ transplant recipients
Costimulation Blockade in Kidney Transplant Recipients
Cardiovascular risk in renal transplant recipients
Lung infections in cardiac transplant recipients
Hypogammaglobulinemia in pediatric kidney transplant recipients
Topical Sirolimus 0.2% Gel for the Management of Tuberous Sclerosis Complex-Related Cutaneous Manifestations: An Interim Analysis of Postmarketing Surveillance in Japan
Determinants of Successful Use of Sirolimus in Renal Transplant Patients
Safety and Effectiveness of Letermovir in Allogenic Hematopoietic Stem Cell Transplantation Recipients: Interim Report of Post-marketing Surveillance in Japan
Immunosuppression Considerations for Older Kidney Transplant Recipients
Sirolimus in renal transplant recipients with malignancies in Germany
Histological spectrum of pulmonary manifestations in kidney transplant recipients on sirolimus inclusive immunosuppressive regimens
Immunomonitoring in Transplant Recipients
Malignant tumors in organ transplant recipients
Costimulation Blockade in Kidney Transplant Recipients
Cardiovascular risk in renal transplant recipients
Lung infections in cardiac transplant recipients
Hypogammaglobulinemia in pediatric kidney transplant recipients
Topical Sirolimus 0.2% Gel for the Management of Tuberous Sclerosis Complex-Related Cutaneous Manifestations: An Interim Analysis of Postmarketing Surveillance in Japan
Determinants of Successful Use of Sirolimus in Renal Transplant Patients
Safety and Effectiveness of Letermovir in Allogenic Hematopoietic Stem Cell Transplantation Recipients: Interim Report of Post-marketing Surveillance in Japan
Immunosuppression Considerations for Older Kidney Transplant Recipients
Sirolimus in renal transplant recipients with malignancies in Germany
Histological spectrum of pulmonary manifestations in kidney transplant recipients on sirolimus inclusive immunosuppressive regimens
Immunomonitoring in Transplant Recipients
Malignant tumors in organ transplant recipients
Costimulation Blockade in Kidney Transplant Recipients
Cardiovascular risk in renal transplant recipients
Lung infections in cardiac transplant recipients
Hypogammaglobulinemia in pediatric kidney transplant recipients
Topical Sirolimus 0.2% Gel for the Management of Tuberous Sclerosis Complex-Related Cutaneous Manifestations: An Interim Analysis of Postmarketing Surveillance in Japan
Determinants of Successful Use of Sirolimus in Renal Transplant Patients
Safety and Effectiveness of Letermovir in Allogenic Hematopoietic Stem Cell Transplantation Recipients: Interim Report of Post-marketing Surveillance in Japan